Back
Biogen Vs. AbbVie Industry Stock Comparison
Sell
48
BIIB
Biogen
Last Price:
213.46
Seasonality Move:
8.62%
Buy
55
ABBV
AbbVie
Last Price:
160.86
Seasonality Move:
1.92%
Sell
48
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
- The current Biogen [BIIB] share price is $216.13. The Score for BIIB is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
AbbVie (ABBV)
is a Buy
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $161.72. The Score for ABBV is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIIB Stock Price Chart
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.49 | Sell |
| Relative Strength Index (14 RSI): | 62.22 | Buy |
| Chaikin Money Flow: | -250282 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (195.9 - 212.18) | Buy |
| Bollinger Bands (100): | (209.4 - 250.46) | Sell |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.11 | Sell |
| Relative Strength Index (14 RSI): | 37.26 | Sell |
| Chaikin Money Flow: | -2822567 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (162.05 - 175.19) | Sell |
| Bollinger Bands (100): | (158.9 - 177.42) | Sell |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 205.9 | Buy |
| 20-day SMA: | 202.01 | Buy |
| 50-day SMA: | 212.41 | Buy |
| 200-day SMA: | 242.37 | Sell |
| 8-day EMA: | 208.46 | Buy |
| 20-day EMA: | 205.91 | Buy |
| 50-day EMA: | 212.95 | Buy |
| 200-day EMA: | 238 | Sell |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 164.75 | Sell |
| 20-day SMA: | 165.71 | Sell |
| 50-day SMA: | 173.61 | Sell |
| 200-day SMA: | 157.22 | Buy |
| 8-day EMA: | 163.64 | Sell |
| 20-day EMA: | 166.61 | Sell |
| 50-day EMA: | 169.41 | Sell |
| 200-day EMA: | 160.76 | Buy |
Biogen Earnings Growth & BIIB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.03 per share, an increase this year of $0.64 per share, and an increase next year of $1.73 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.20 per share, an increase this year of $0.09 per share, and an increase next year of $0.84 per share.
Biogen Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||